TSE:HSM - Helius Medical Technologies Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$3.05 +0.10 (+3.39 %)
(As of 05/19/2019 04:00 PM ET)
Previous CloseC$3.05
Today's RangeC$2.89 - C$3.05
52-Week RangeC$2.35 - C$17.20
Volume7,900 shs
Average Volume30,431 shs
Market CapitalizationC$78.89 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. Helius Medical Technologies, Inc. is headquartered in Newtown, Pennsylvania.

Receive HSM News and Ratings via Email

Sign-up to receive the latest news and ratings for HSM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone215-944-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.16 million
Cash FlowC$0.79 per share
Book ValueC$0.47 per share

Profitability

Miscellaneous

Employees25
Market CapC$78.89 million
Next Earnings Date8/8/2019 (Estimated)
OptionableNot Optionable

Helius Medical Technologies (TSE:HSM) Frequently Asked Questions

What is Helius Medical Technologies' stock symbol?

Helius Medical Technologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HSM."

How were Helius Medical Technologies' earnings last quarter?

Helius Medical Technologies Inc (TSE:HSM) posted its quarterly earnings data on Thursday, March, 14th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.27) by $0.02. The business had revenue of $0.63 million for the quarter. View Helius Medical Technologies' Earnings History.

When is Helius Medical Technologies' next earnings date?

Helius Medical Technologies is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for Helius Medical Technologies.

Has Helius Medical Technologies been receiving favorable news coverage?

News articles about HSM stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Helius Medical Technologies earned a media sentiment score of 1.9 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are some of Helius Medical Technologies' key competitors?

What other stocks do shareholders of Helius Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helius Medical Technologies investors own include Sleep Country Canada (ZZZ), PrairieSky Royalty (PSK), Maxar Technologies (MAXR), BlackBerry (BB) and Denbury Resources (DNR).

Who are Helius Medical Technologies' key executives?

Helius Medical Technologies' management team includes the folowing people:
  • Mr. Philippe Deschamps, Chairman, CEO & Pres (Age 57)
  • Ms. Joyce N. LaViscount, CFO & COO (Age 57)
  • Ms. Jennifer Laux M.B.A., Chief Commercialization Officer (Age 52)
  • Dr. Jonathan Mark Sackier, Chief Medical Officer (Age 61)
  • Diane Carman, Sec.

How do I buy shares of Helius Medical Technologies?

Shares of HSM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Helius Medical Technologies' stock price today?

One share of HSM stock can currently be purchased for approximately C$3.05.

How big of a company is Helius Medical Technologies?

Helius Medical Technologies has a market capitalization of C$78.89 million and generates C$1.16 million in revenue each year. Helius Medical Technologies employs 25 workers across the globe.

What is Helius Medical Technologies' official website?

The official website for Helius Medical Technologies is http://heliusmedical.com.

How can I contact Helius Medical Technologies?

The company can be reached via phone at 215-944-6100.


MarketBeat Community Rating for Helius Medical Technologies (TSE HSM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  5 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about Helius Medical Technologies and other stocks. Vote "Outperform" if you believe HSM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HSM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: Stock Symbol

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel